The development and reliability of the RAATE-CE.
The Recovery Attitude And Treatment Evaluator-Clinical Evaluation (RAATE-CE) utilizes a brief, structured clinical interview that assesses five key dimensions that produce a clinically relevant and useful severity profile of the patient for making placement, continued stay, discharge, and treatment-planning decisions. The RAATE-CE also measures treatment progress. These five dimensions are: (A) degree of resistance to treatment (including denial of addiction problems); (B) degree of resistance to continuing care (including self-help groups); (C) acuity of biomedical problems; (D) acuity of psychiatric-psychological problems; and (E) the degree to which the psychosocial environment is supportive or detrimental to recovery. Data on 139 publicly funded, high-severity subjects suggest that the RAATE-CE demonstrates an interrater reliability across the five dimensions between .59 and .77, and an internal consistency reliability range between .65 and .87.
Smith
M B
MB
CATOR/New Standards, Inc., St. Paul, MN 55116.
Hoffmann
N G
NG
Nederhoed
R
R
D000328:Adult; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation*; D003131:Combined Modality Therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000523:psychology / Q000534:rehabilitation*; D005260:Female; D006801:Humans; D013287:Illicit Drugs; D008297:Male; D015588:Observer Variation; D010043:Outcome and Process Assessment, Health Care; D010552:Personality Assessment / Q000706:statistics & numerical data*; D011594:Psychometrics; D011619:Psychotropic Drugs; D015203:Reproducibility of Results; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*
D013287:Illicit Drugs; D011619:Psychotropic Drugs